Health Care & Life Sciences » Pharmaceuticals | Tus-Guhan Group Corp. Ltd.

Tus-Guhan Group Corp. Ltd. A | Ownership

Companies that own Tus-Guhan Group Corp. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
China Universal Asset Management Co., Ltd.
9,455,458
4.24%
-9,938,138
0.12%
12/31/2017
Golden Eagle Asset Management Co., Ltd.
6,400,516
2.87%
300,000
0.27%
12/31/2017
Truvalue Asset Management Co. Ltd.
38,000
0.02%
38,000
0%
12/31/2016
Morgan Stanley Huaxin Fund Management Co., Ltd.
24,200
0.01%
-164,600
0%
12/31/2017
China Asset Management Co., Ltd.
8,348
0%
-440,717
0%
12/31/2017
Da Cheng Fund Management Co., Ltd.
1,200
0%
1,200
0%
12/31/2017
UBS SDIC Fund Management Co., Ltd.
0
0%
-2,360,611
0%
12/31/2017
Yinhua Fund Management Co., Ltd.
0
0%
-4,499,972
0%
12/31/2017
Chang Xin Asset Management Co., Ltd.
0
0%
-345,305
0%
12/31/2017

About Tus-Guhan Group Corp.

View Profile
Address
No. 33 Yangliu Road
Hengyang Hunan 421001
China
Employees -
Website http://www.guhan.com
Updated 07/08/2019
Tus-Guhan Group Corp., Ltd. engages in the research and development, manufacture, and sale of traditional and western medicine, and biological products. It offers Chinese medicine; chemical composition such as lomefloxacin hydrochloride and sodium chloride injection, clindamycin phosphate injection, potassium chloride and glucose injection; tincture and health products. The company was founded in 1956 and is headquartered in Hengyang, China.